A Case of Periocular Capillary Hemangiomas Treated With Propranolol as a Single Therapy
Journal of the Korean Ophthalmological Society
;
: 607-611, 2012.
Artigo
em Coreano
| WPRIM
| ID: wpr-143957
ABSTRACT
PURPOSE:
To report a case of periorbital infantile capillary hemangioma treated with propranolol as a single therapy. CASESUMMARY:
A 3-month-old girl with a growing red-purple mass on the right lower eyelid visited our clinic. The patient was diagnosed with capillary hemagioma by imaging studies. The mass had grown rapidly, and the visual axis was obscured in the follow-up. Oral propranolol therapy was initiated at a starting dose of 0.17 mg/kg at 8-hour intervals. After 2 doses, the propranolol was doubled, and after another 2 doses, the daily dose of 0.67 mg/kg divided into 3 was maintained. Three days after the initiation of the treatment, the color of the hemangioma had changed from red-purple to light purple, and the hemangioma had softened. The hemangioma continued to respond well with no side effects in the following 10 months.CONCLUSIONS:
The authors suggest that oral propranolol treatment as a possibility of an effective and safe option for the vision-threatening periorbital capillary hemangioma as a single therapy.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Propranolol
/
Vértebra Cervical Áxis
/
Capilares
/
Seguimentos
/
Hemangioma Capilar
/
Pálpebras
/
Hemangioma
/
Luz
Tipo de estudo:
Estudo observacional
/
Estudo prognóstico
Limite:
Humanos
/
Lactente
Idioma:
Coreano
Revista:
Journal of the Korean Ophthalmological Society
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS